Assist. Prof. Dr. Natalia Bilousova – Pharmaceutical care  –  Best Researcher Award 

Assist. Prof. Dr. Natalia Bilousova - Pharmaceutical care  -  Best Researcher Award 

Shupyk National Healthcare University of Ukraine -  Ukraine 

Author Profile 

GOOGLE SCHOLAR 

🎓 Early academic pursuits

Natalia Bilousova embarked on her academic journey with a profound interest in clinical pharmacology. she earned her mph and subsequently a phd, laying a strong foundation in pharmaceutical sciences. her commitment to academic excellence led her to pursue a post-doctoral role at the cardiology department of the shupyk national healthcare university of ukraine in kyiv. early on, she demonstrated a deep inclination toward merging clinical practice with evidence-based research, which later shaped her career trajectory.

💼 Professional endeavors

With over 25 years of professional experience, natalia has worn many hats, including clinical pharmacist, academician, and researcher. she currently serves as an associate professor at the shupyk national healthcare university of ukraine. amidst wartime disruptions, she took part in an academic mobility program in 2022 at masaryk university, czech republic, showing her resilience and dedication to global health education. her participation in consultancy projects with pharmacy chains like “bazhaemo zdorovia” and “apteka nyzkykh tsin” showcases her practical engagement with the healthcare sector. her work in the domain of power electronics provides a novel lens for integrating digital systems in pharmaceutical education.

🔬 Contributions and research focus

Natalia’s research interests span across pharmacology, healthcare policy, pharmaceutical care in cardiovascular diseases, and mental health. her notable contributions include three clinical pharmacology guidelines for managing chronic coronary syndrome, elevated blood pressure, and ischemic heart disease in multidisciplinary teams. she’s also deeply involved in developing Pharmaceutical care continuing professional development (cpd) courses and pharmaceutical training modules. her innovative outlook ties in health technology assessment with real-time patient care — offering new dimensions of analysis, akin to the precision and integration found in power electronics applications.

🌍 Impact and influence

As a national and international speaker, natalia frequently addresses audiences via webcardio.org and scientific forums. her influence spans academia, industry, and public health Pharmaceutical care organizations. she plays an active role in shaping public policies through her board membership in public health and educational groups. her collaborations with pharmaceutical giants like teva, ratiopharm, arterium, and wörwag pharma reflect her trusted expertise in market research and medical promotion. her scholarly presence extends to the conceptual design of pharmaceutical care systems — a model as efficient and structured as a power electronics control scheme in high-demand environments.

📊 Academic cites

Natalia Bilousova’s academic contributions have garnered a citation index of 7 on google scholar and 1 on scopus. while modest, these numbers reflect her growing impact in niche research Pharmaceutical care areas such as health technology assessment and mental health-focused pharmaceutical care. her scholarly output includes six isbn-registered publications, some of which are monographs and methodological guides, including her 2024 work on pharmaceutical care for mental health patients.

📚 Legacy and future contributions

Natalia’s legacy is rooted in her dedication to refining pharmaceutical education and care practices. her recent books delve into topics like professional digital competence and medical technology assessment, emphasizing the evolving role of pharmacists in an increasingly tech-driven world. she is poised to continue her efforts in education transformation, particularly Pharmaceutical care through digitalization and interprofessional healthcare collaboration. future contributions are expected to address mental health services and integrative care models that could revolutionize pharmacy training — much like how power electronics has revolutionized modern energy systems.

Notable Publications 

  • Title: Conceptual model of pharmaceutical care for patients with coronary heart disease and comorbid conditions in Ukraine
    Author: N. Bilousova
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title: Research of affordability to essential medicines for coronary heart disease in Ukraine
    Authors: N. Bilousova, N. Tkachenko, N. Kozhuharyova, M. Dolzhenko
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title : Adherence to treatment of patients with coronary heart disease and comorbid conditions: influence of socio-economic factors during martial law in Ukraine (first report)
    Authors: N.A. Bilousova, V.I. Nesukai, T.V. Simahina, M.M. Dolzhenko, O.P. Shmatenko, et al.
    Journal: Ukrainian Journal of Military Medicine

  • Title: An analysis of prescriptions for coronary heart disease with comorbid conditions in health care institutions of Ukraine
    Authors: N.A. Bilousova, M.M. Dolzhenko
    Journal: Current Issues in Pharmacy and Medicine: Science and Practice

  • Title: Preferences in the choice of original and generic drugs: pharmaceutical care for patients with coronary heart disease and comorbid conditions
    Authors: M.M. Dolzhenko, N.A. Bilousova, V.A. Nesukai, T.V. Simahina, et al.
    Journal: Modern Medical Technologies (Сучасні медичні технології)

Assist. Prof. Dr.  Hagar Mohamed Yousef Aly – Medicine and Health Sciences – Best Researcher Award

Assist. Prof. Dr.  Hagar Mohamed Yousef Aly - Medicine and Health Sciences - Best Researcher Award

Liwa College - United Arab Emirates

Author Profile 

SCOPUS 

ORCID 

🎓 Early academic pursuits

Dr. Hagar Mohamed Yousef Aly began her academic journey with a strong foundation in biochemistry and chemistry. she earned her bachelor of science degree in biochemistry/chemistry from alexandria university, egypt. her passion for medical biochemistry led her to pursue a master's degree from the medical research institute at alexandria university, where she deepened her knowledge in the field. driven by a desire to contribute to the scientific community, she further advanced her academic qualifications by obtaining a phd in medical biochemistry/chemistry from the same institute. throughout her academic journey, dr. aly exhibited exceptional dedication and commitment to understanding the intricate mechanisms of biochemistry and molecular biology.

💼 Professional endeavors

Dr. Aly's professional career spans over 15 years of dedicated service in academia across egypt, the kingdom of saudi arabia (ksa), and the united arab emirates (uae). she began her career as a lecturer of chemistry and biochemistry at alexandria university, where she imparted knowledge in various chemistry-related courses including biophysical chemistry, analytical chemistry, organic chemistry, and inorganic chemistry. her exceptional teaching skills and subject-matter expertise allowed her to transition to batterjie medical college in jeddah, ksa, where she served as a lecturer of medicinal chemistry and biochemistry. during her tenure there, she introduced problem-based learning (pbl) methodology in collaboration with maastricht university, holland, providing students with a modern and practical approach to learning. presently, dr. aly holds the position of assistant professor in medical biochemistry/chemistry at liwa college, abu dhabi, uae. she has been instrumental in delivering high-quality education in clinical chemistry, genetics, molecular biology, hematology, and pathophysiology, contributing significantly to shaping the next generation of medical professionals.

🧪 Contributions and research focus

Dr. Aly's research focus is primarily centered around molecular biology, clinical chemistry, and cancer research. her extensive work in the field of gastric cancer has been recognized through Medicine and Health Sciences several high-impact publications. she has contributed immensely to understanding gene profiling in gastric cancer by investigating the expression levels of genes such as sec13, smad7, ghrl, long non-coding rna ghrlos, and hif-1α in gastric cancer patients. her research has paved the way for potential breakthroughs in early diagnosis and treatment of gastric cancer. additionally, dr. aly has explored the role of cannabinoid receptors in chronic hepatitis c virus in obese and non-obese patients, highlighting her diverse research interests. she has also contributed to advancing drug delivery mechanisms using high-frequency ultrasound-assisted techniques combined with hematite iron oxide nanoparticles for lung cancer treatment, showcasing her interdisciplinary research capabilities in nanotechnology and cancer therapeutics.

🏅 Accolades and recognition

Dr. Aly's outstanding contributions to academia and research have earned her notable recognition within the scientific community. she has presented her work at prestigious international Medicine and Health Sciences conferences, including the 45th and 46th international annual conference of the egyptian society of histology and cytology, where her groundbreaking research on liver enzymes and cancer gene profiling was highly appreciated. her recent publication in cancer nanotechnology journal, focusing on sono-photodynamic lung cancer treatment using chia, cress, and flax conjugated hematite iron oxide nanoparticles, has received commendation for its innovative approach to cancer treatment. dr. aly's academic excellence and impactful research have solidified her position as a distinguished figure in the field of medical biochemistry and chemistry.

🌍 Impact and influence

Throughout her career, dr. aly has significantly impacted the academic and scientific communities. her expertise in clinical chemistry and molecular biology has shaped the knowledge and skills of countless medical students, who now contribute to the global healthcare system. her research on gastric cancer, hepatitis c, and cancer therapeutics has influenced further investigations in Medicine and Health Sciences these areas, providing new perspectives for effective treatment options. by integrating problem-based learning (pbl) methodologies in medical education, dr. aly has revolutionized the learning experience for students, fostering critical thinking and practical application of knowledge. her academic influence extends beyond teaching, as she continues to inspire future researchers and medical professionals through her groundbreaking research and innovative approaches.

👣 Legacy and future contributions

Dr. Aly's legacy in the field of medical biochemistry and chemistry is marked by her unwavering dedication to education, research, and innovation. as she continues her academic journey at liwa college, abu dhabi, she remains committed to advancing scientific knowledge and improving healthcare outcomes through her research. her future contributions are poised to bring new insights into cancer therapeutics, gene profiling, and clinical chemistry, further enhancing the understanding and treatment of various medical conditions. dr. aly envisions continuing her role as a mentor, inspiring young researchers and students to explore the fascinating world of biochemistry and medical science. her profound impact on education, research, and healthcare solidifies her status as a visionary leader in the field.

📜 Notable publications

  • Title: Engineering Solutions in Healthcare: The Government's Role in Decision-Making
    Author(s): Mahmoud Khalifa, Sally M. Elsayed, Rashed Alrasheed, Hagar M. Mohamed
    Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20

  • Title: Ethical and Legal Issues of Regenerative Medicine in the UAE
    Author(s): Mahmoud Khalifa, Amina Toumi, Hagar M. Mohamed
    Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20

  • Title: Navigating Healthcare Structure: Government Policies and Their Impact on Decisions
    Author(s): Mahmoud Khalifa, Samah Anwar, Sally M. Elsayed, Hagar M. Mohamed
    Journal: 2024 International Conference on Decision Aid Sciences and Applications (DASA), 2025-01-20

  • Title: High-frequency ultrasound-assisted drug delivery of chia, cress, and flax conjugated hematite iron oxide nanoparticle for sono-photodynamic lung cancer treatment in vitro and in vivo
    Author(s): Abd El-Kaream S.A., Zedan D.F.M., Mohamed H.M., Soliman A.S.M., El-Kholey S.M., Nasra M.K.E.-D.
    Journal: Cancer Nanotechnology, 2024

  • Title: Future Directions: The Role of Government in Shaping Healthcare Engineering Decisions
    Author(s): Hagar M. Mohamed, Mahmoud Khalifa
    Journal: World Research of Business Administration Journal, 2024-11

Assoc. Prof. Dr Meenakshi Dhanawat – Pharmacy – Best Researcher Award

Assoc. Prof. Dr Meenakshi Dhanawat - Pharmacy - Best Researcher Award

Amity Institute of Pharmacy, Amity University Haryana - India 

AUTHOR PROFILE 

SCOPUS 

ORCID 

EARLY ACADEMIC PURSUITS 🎓

Meenakshi Dhanawat's academic journey began with a solid foundation in Pharmaceutical Sciences, completing her B. Pharm at Lachoo Memorial College of Science & Technology, Jodhpur, Rajasthan in 2005. She further honed her expertise by pursuing a Master's in Medicinal Chemistry at the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, where she developed a deep interest in synthetic chemistry, drug delivery systems, and nanotechnology. Her passion for advancing pharmaceutical science led her to complete a Ph.D. in Pharmaceutical Chemistry from the Department of Pharmaceutics at IIT-BHU, Varanasi, in 2012. During her doctoral studies, she focused on the development of innovative drug delivery systems and therapeutic strategies to enhance drug bioavailability.

PROFESSIONAL ENDEAVORS 💼

Dr. Dhanawat has had a dynamic professional career spanning over 17 years in teaching and research. She began her career as a Quality Manager at Nector Life Science Ltd., where she contributed to ensuring the quality and efficacy of pharmaceutical products. She then served as an Assistant Professor and Head of the Department at Mewar University, Chittorgarh, Rajasthan, from 2013 to 2016. Dr. Dhanawat continued her academic journey at Maharishi Markandeshwar (Deemed to be University) in Mullana, Ambala, where she held the position of Assistant Professor and later Associate Professor. Her contributions to academia expanded as she joined Amity University in Gurugram as an Associate Professor in December 2022, where she continues to shape the future of pharmacy education.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Dr. Dhanawat's research expertise lies in synthetic chemistry, heterocyclic chemistry, nanotechnology, and drug delivery systems. She has worked extensively on designing prodrugs and co-drug drug delivery systems to improve therapeutic efficacy. Her research also focuses on the complexation of polymers in drug delivery systems, aiming to enhance the controlled release of Pharmacy active pharmaceutical ingredients. Over the years, she has contributed significantly to the field through numerous publications and innovative research work in pharmaceutical sciences. She has authored 71 research/review articles, contributed to six books, and edited one book. Her work on drug design and delivery has further extended to patented innovations aimed at advancing pharmaceutical technology.

ACCELERATING IMPACT THROUGH PATENTS AND INNOVATIONS 📑

Dr. Dhanawat's innovative spirit is exemplified by her contribution to pharmaceutical technology through five granted patents. These patents include designs for cutting-edge pharmaceutical Pharmacy devices, such as an inclined paw grip and climbing apparatus for rodents, a handheld nanoparticle size analyzer, and intelligent dosing control systems for pharmaceuticals. Additionally, she has pioneered innovations in pharmaceutical waste disposal units and UV chambers for pharmaceutical processes. These patents not only underscore her technical expertise but also contribute significantly to the advancement of the pharmaceutical and healthcare industries.

ACCOLADES AND RECOGNITION 🏆

Dr. Dhanawat’s outstanding contributions to the field of pharmaceutical sciences have earned her numerous accolades and recognition within academic and professional circles. She is a Pharmacy sought-after reviewer for scientific journals and has contributed to several thematic issues in the field. Her extensive research, innovative patents, and contributions to academia have made her a recognized leader in pharmaceutical sciences. Her achievements in drug design, nanotechnology, and polymer chemistry continue to inspire the next generation of researchers and practitioners in the field.

LEGACY AND INFLUENCE ON FUTURE RESEARCH 🌍

Dr. Dhanawat's legacy is marked by her impact on the development of novel drug delivery systems, which have improved the efficacy of pharmaceuticals and enhanced patient outcomes. Through her research, she has inspired many students and professionals to explore the intersection of synthetic chemistry, nanotechnology, and drug delivery. As a mentor and educator, she continues to guide the future of pharmaceutical sciences, fostering innovation in drug design and therapeutic systems. Her forward-thinking research, combined with her extensive academic experience, ensures that she remains a key influencer in shaping future pharmaceutical technologies.

NOTABLE PUBLICATIONS 

  1. Title: Auvelity: A New Era in Medicine - Unraveling the Multifaceted Benefits of Dextromethorphan/Bupropion Combination
    Authors: Anchal Dhawan, Sunayna Choudhary, Sumeet Gupta, Abhishek Chander, Meenakshi Dhanawat
    Journal: Current Drug Therapy, 2024-09
    DOI: 10.2174/1574885519666230913105725
  2. Title: Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals
    Authors: Dakshita Hardatt, Manju Devi, Sonal Vyas, Gurvinder Singh, Jyoti Jain, Sumeet Gupta, Meenakshi Dhanawat
    Journal: Current Diabetes Reviews, 2024-01
    DOI: 10.2174/1573399819666230331083715
  3. Title: Quinazolinone: Pharmacophore with Endless Pharmacological Actions
    Authors: Meenakshi Dhanawat, Sumeet Gupta, Somdutt Mujwar
    Journal: Current Indian Science, 2023
    DOI: 10.2174/2210299X02666221125101550
  4. Title: Synthesis, Biological Evaluation and in Silico Studies of Some New Analogues of 3,5-Disubstituted Thiazolidin-2,4-Dione
    Authors: Harsh Kumar, Aastha Sharma, Davinder Kumar, Minakshi Gupta Marwaha, Meenakshi Dhanawat, Navidha Aggarwal, Rakesh Kumar Marwaha
    Journal: Future Medicinal Chemistry, 2023-12
    DOI: 10.4155/fmc-2023-0237
  5. Title: Assessment of Peripheral Neuropathy Pain by Biothesiometer in Diabetes Mellitus Patients
    Authors: Manju Devi, Sukhdeep Singh, Meenakshi Dhanawat, Kirti Gupta, Sumeet Gupta, B K Agarwal, Inderjeet Verma, Parminder Nain
    Journal: Journal of Young Pharmacists, 2023-01-01
    DOI: 10.5530/097515050431

Assoc Prof Dr. Fatemeh Bagheri – Biotechnology – Best Researcher Award

Assoc Prof Dr. Fatemeh Bagheri - Biotechnology - Best Researcher Award

Tarbiat Modares University - Iran

AUTHOR PROFILE

SCOPUS

ORCID

EARLY ACADEMIC PURSUITS

Fatemeh Bagheri's academic journey is marked by a strong foundation in the field of Cell & Molecular Biology. Beginning with a Bachelor's degree from the University of Isfahan, Bagheri then pursued a Master's degree and subsequently a Ph.D. at the University of Tehran, where they excelled, ranking first in both their graduating classes. Bagheri's exceptional academic performance was recognized early on, as they were selected as an Exceptional Talent in their Ph.D. program without the need for an entrance exam.

PROFESSIONAL ENDEAVORS

As an Academic Staff member at Tarbiat Modares University, Fatemeh Bagheri has established themselves as a prominent figure in the field of tissue engineering and regenerative medicine. Their professional journey has been characterized by a commitment to advancing knowledge and innovation in areas such as drug and gene delivery, nanobiomaterials, cell therapy, and stem cells.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOTECHNOLOGY

Bagheri's contributions to the field of tissue engineering and regenerative medicine are extensive, spanning various aspects of biomaterials, drug delivery systems, and stem cell technologies. Their research endeavors have resulted in numerous publications in reputable journals and chapters in prestigious books, Biotechnology focusing on topics such as scaffold design, tissue regeneration, and therapeutic delivery systems.

IMPACT AND INFLUENCE

Fatemeh Bagheri's research has made a significant impact on the scientific community, as evidenced by their extensive publication record and high citation index. Their work has contributed to advancing understanding and innovation in areas critical to tissue engineering and regenerative medicine, Biotechnology  with implications for improving healthcare outcomes and patient quality of life.

ACADEMIC CITES

Bagheri's research findings have been widely cited within the academic community, reflecting the relevance and significance of their contributions to the field. Their work has influenced and informed further research in tissue engineering, drug delivery, and stem cell therapies, contributing to the advancement of scientific knowledge and innovation.

LEGACY AND FUTURE CONTRIBUTIONS

Fatemeh Bagheri's legacy lies in their dedication to advancing the frontiers of tissue engineering and regenerative medicine. Their ongoing research and scholarly pursuits hold the promise of furthering understanding and innovation in critical areas of healthcare. Bagheri's future contributions have the potential to impact patient care and shape the future of regenerative medicine, leaving a lasting legacy in the field.

NOTABLE PUBLICATIONS

ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis   2024(1)

Inhalation of Spray-Dried Extract of Salvia rosmarinus Spenn Alleviates Lung Inflammatory, Oxidative, and Remodeling   2024(1)

High-intensity intermittent training ameliorates methotrexate-induced acute lung injury   2024

Alendronate releasing silk fibroin 3D bioprinted scaffolds for application in bone tissue engineering 2024

Genipin-Cross-Linked Silk Fibroin/Alginate Dialdehyde Hydrogel with Tunable Gelation Kinetics, Degradability  2024